On February 19, 2019 Corcept Therapeutics Incorporated (NASDAQ: CORT) reported it will report its audited 2018 fourth quarter and full-year financial results and provide a corporate update on February 25, 2019 (Press release, Corcept Therapeutics, FEB 19, 2019, https://ir.corcept.com/news-releases/news-release-details/corcept-therapeutics-announce-audited-financial-results-provide [SID1234533488]). The company will host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call Information

To participate, dial 1-888-220-8451 from the United States or 1-323-794-2588 internationally approximately ten minutes before the start of the call. The passcode will be 6598298.

A replay will be available through March 11, 2019 at 1-888-203-1112 from the United States and 1-719-457-0820 internationally. The passcode will be 6598298.